• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SMN1阴性近端脊髓性肌萎缩症的临床和遗传多样性

Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies.

作者信息

Peeters Kristien, Chamova Teodora, Jordanova Albena

机构信息

1 Molecular Neurogenomics Group, Department of Molecular Genetics, VIB, University of Antwerp, Antwerpen 2610, Belgium 2 Neurogenetics Laboratory, Institute Born-Bunge, University of Antwerp, Antwerpen 2610, Belgium

3 Department of Neurology, Medical University-Sofia, Sofia 1000, Bulgaria

出版信息

Brain. 2014 Nov;137(Pt 11):2879-96. doi: 10.1093/brain/awu169. Epub 2014 Jun 25.

DOI:10.1093/brain/awu169
PMID:24970098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4208460/
Abstract

Hereditary spinal muscular atrophy is a motor neuron disorder characterized by muscle weakness and atrophy due to degeneration of the anterior horn cells of the spinal cord. Initially, the disease was considered purely as an autosomal recessive condition caused by loss-of-function SMN1 mutations on 5q13. Recent developments in next generation sequencing technologies, however, have unveiled a growing number of clinical conditions designated as non-5q forms of spinal muscular atrophy. At present, 16 different genes and one unresolved locus are associated with proximal non-5q forms, having high phenotypic variability and diverse inheritance patterns. This review provides an overview of the current knowledge regarding the phenotypes, causative genes, and disease mechanisms associated with proximal SMN1-negative spinal muscular atrophies. We describe the molecular and cellular functions enriched among causative genes, and discuss the challenges in the post-genomics era of spinal muscular atrophy research.

摘要

遗传性脊髓性肌萎缩症是一种运动神经元疾病,其特征是由于脊髓前角细胞变性导致肌肉无力和萎缩。最初,该疾病被单纯认为是由5号染色体长臂13区(5q13)上功能缺失的运动神经元存活基因1(SMN1)突变引起的常染色体隐性疾病。然而,新一代测序技术的最新进展揭示了越来越多被称为非5q型脊髓性肌萎缩症的临床病症。目前,16个不同的基因和一个未解决的基因座与近端非5q型相关,具有高度的表型变异性和多样的遗传模式。本综述概述了目前关于近端SMN1阴性脊髓性肌萎缩症的表型、致病基因和疾病机制的知识。我们描述了致病基因中富集的分子和细胞功能,并讨论了脊髓性肌萎缩症研究的后基因组时代所面临的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb8/4208460/aa7a1c1af4f2/awu169f4p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb8/4208460/d313c98865ee/awu169f1p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb8/4208460/fd02eec486aa/awu169f2p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb8/4208460/64b07d59ee0d/awu169f3p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb8/4208460/aa7a1c1af4f2/awu169f4p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb8/4208460/d313c98865ee/awu169f1p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb8/4208460/fd02eec486aa/awu169f2p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb8/4208460/64b07d59ee0d/awu169f3p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cb8/4208460/aa7a1c1af4f2/awu169f4p.jpg

相似文献

1
Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies.SMN1阴性近端脊髓性肌萎缩症的临床和遗传多样性
Brain. 2014 Nov;137(Pt 11):2879-96. doi: 10.1093/brain/awu169. Epub 2014 Jun 25.
2
Spinal muscular atrophies.脊髓性肌萎缩症
Pediatr Clin North Am. 2015 Jun;62(3):743-66. doi: 10.1016/j.pcl.2015.03.010. Epub 2015 Apr 11.
3
Targeted sequencing with expanded gene profile enables high diagnostic yield in non-5q-spinal muscular atrophies.靶向测序结合扩展基因谱可提高非 5q-脊髓性肌萎缩症的诊断产量。
Hum Mutat. 2018 Sep;39(9):1284-1298. doi: 10.1002/humu.23560. Epub 2018 Jul 25.
4
Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.BICD2基因突变所致脊髓性肌萎缩症的表型和分子学见解
Brain. 2015 Feb;138(Pt 2):293-310. doi: 10.1093/brain/awu356. Epub 2014 Dec 14.
5
An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).常染色体隐性遗传性脊髓性肌萎缩症(SMA)中存活运动神经元基因(SMN1)突变谱的更新
Hum Mutat. 2000;15(3):228-37. doi: 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9.
6
Novel BICD2 mutation in a Japanese family with autosomal dominant lower extremity-predominant spinal muscular atrophy-2.一个患有常染色体显性下肢为主型脊髓性肌萎缩症2型的日裔家族中的新型BICD2突变。
Brain Dev. 2018 Apr;40(4):343-347. doi: 10.1016/j.braindev.2017.12.001. Epub 2017 Dec 19.
7
Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.常染色体隐性遗传性脊髓性肌萎缩症5q13染色体上候选基因的分子分析:未患病个体中SMN基因纯合缺失的证据。
Hum Mol Genet. 1995 Oct;4(10):1927-33. doi: 10.1093/hmg/4.10.1927.
8
High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients.摩洛哥成年型脊髓性肌萎缩症患者中SMN1基因缺失的高发生率。
J Neurol. 2003 Oct;250(10):1209-13. doi: 10.1007/s00415-003-0186-1.
9
Molecular analysis of the SMN1 and NAIP genes in Iranian patients with spinal muscular atrophy.伊朗脊髓性肌萎缩症患者中SMN1和NAIP基因的分子分析
Ann Acad Med Singap. 2007 Nov;36(11):937-41.
10
The Genetics of Spinal Muscular Atrophy: Progress and Challenges.脊髓性肌萎缩症的遗传学:进展与挑战
Neurotherapeutics. 2015 Apr;12(2):290-302. doi: 10.1007/s13311-014-0314-x.

引用本文的文献

1
Evaluating Therapeutic Outcomes in Spinal Muscular Atrophy: An Indian Experience.评估脊髓性肌萎缩症的治疗效果:印度经验
Ann Indian Acad Neurol. 2025 Jul 1;28(4):547-553. doi: 10.4103/aian.aian_670_24. Epub 2025 Aug 7.
2
Clinical and Gene-Specific Sequencing to Enhance the Clinical Sensitivity of Spinal Muscular Atrophy Diagnostic Testing.临床及基因特异性测序以提高脊髓性肌萎缩症诊断检测的临床敏感性
Hum Mutat. 2023 Oct 19;2023:6436853. doi: 10.1155/2023/6436853. eCollection 2023.
3
Unraveling the genetic mysteries of spinal muscular atrophy in Chinese families.

本文引用的文献

1
Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy.泛素稳态失调和β-连环蛋白信号通路的失调促进了脊髓性肌萎缩症的发生。
J Clin Invest. 2014 Apr;124(4):1821-34. doi: 10.1172/JCI71318. Epub 2014 Mar 3.
2
EXOSC3 mutations in pontocerebellar hypoplasia type 1: novel mutations and genotype-phenotype correlations.1型脑桥小脑发育不全中的EXOSC3突变:新突变及基因型-表型相关性
Orphanet J Rare Dis. 2014 Feb 13;9:23. doi: 10.1186/1750-1172-9-23.
3
Pontobulbar palsy and sensorineural deafness (Brown-Vialetto-van Laere syndrome): A case from Northwest Iran.
揭示中国家庭脊髓性肌萎缩症的遗传奥秘。
Orphanet J Rare Dis. 2025 Jan 15;20(1):25. doi: 10.1186/s13023-024-03523-0.
4
c.5C>G (p.Ala2Gly) missense variant, a challenging molecular SMA diagnosis associated with mild disease, preserves SMN nuclear gems in patient-specific fibroblasts.c.5C>G(p.Ala2Gly)错义变体,一种与轻度疾病相关的具有挑战性的分子性脊髓性肌萎缩症诊断,在患者特异性成纤维细胞中保留了SMN核小体。
Front Genet. 2024 Jul 30;15:1406819. doi: 10.3389/fgene.2024.1406819. eCollection 2024.
5
Phenotype Presentation and Molecular Diagnostic Yield in Non-5q Spinal Muscular Atrophy.非5q型脊髓性肌萎缩症的表型表现及分子诊断率
Neurol Genet. 2023 Jul 17;9(4):e200087. doi: 10.1212/NXG.0000000000200087. eCollection 2023 Aug.
6
Early Development of Spinal Deformities in Children Severely Affected with Spinal Muscular Atrophy after Gene Therapy with Onasemnogene Abeparvovec-Preliminary Results.接受onasemnogene abeparvovec基因治疗后脊髓性肌萎缩症严重患儿脊柱畸形的早期发展——初步结果
Children (Basel). 2023 Jun 2;10(6):998. doi: 10.3390/children10060998.
7
Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME): three new cases and review of the mutational spectrum.脊肌萎缩伴进行性肌阵挛性癫痫(SMA-PME):三例新病例及突变谱分析。
Ital J Pediatr. 2023 Jun 6;49(1):64. doi: 10.1186/s13052-023-01474-z.
8
Spinal muscular atrophy carrier frequency in Saudi Arabia.沙特阿拉伯的脊髓性肌萎缩症携带者频率。
Mol Genet Genomic Med. 2022 Nov;10(11):e2049. doi: 10.1002/mgg3.2049. Epub 2022 Sep 5.
9
Expanding the phenotypic variability of MORC2 gene mutations: From Charcot-Marie-Tooth disease to late-onset pure motor neuropathy.扩展 MORC2 基因突变的表型变异性:从遗传性运动感觉神经病到迟发性纯运动神经病。
Hum Mutat. 2022 Dec;43(12):1898-1908. doi: 10.1002/humu.24445. Epub 2022 Aug 18.
10
Combination Therapy with Nusinersen and Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy Type I.I型脊髓性肌萎缩症中诺西那生钠与阿那西普基因载体-xioi的联合治疗
J Clin Med. 2021 Nov 26;10(23):5540. doi: 10.3390/jcm10235540.
脑桥延髓麻痹和感音神经性耳聋(布朗 - 维亚莱托 - 范莱尔综合征):来自伊朗西北部的一例病例。
J Pediatr Neurosci. 2013 Sep;8(3):257-9. doi: 10.4103/1817-1745.123709.
4
Advances in motor neurone disease.运动神经元病的研究进展。
J R Soc Med. 2014 Jan;107(1):14-21. doi: 10.1177/0141076813511451.
5
Late-onset spinal motor neuronopathy - a common form of dominant SMA.晚发性脊髓运动神经元病——一种常见的显性 SMA 形式。
Neuromuscul Disord. 2014 Mar;24(3):259-68. doi: 10.1016/j.nmd.2013.11.010. Epub 2013 Nov 26.
6
Dominant spinal muscular atrophy due to BICD2: a novel mutation refines the phenotype.由BICD2引起的显性脊髓性肌萎缩症:一种新突变完善了表型。
J Neurol Neurosurg Psychiatry. 2014 May;85(5):590-2. doi: 10.1136/jnnp-2013-306777. Epub 2013 Dec 11.
7
Novel dynein DYNC1H1 neck and motor domain mutations link distal spinal muscular atrophy and abnormal cortical development.新型动力蛋白 DYNC1H1 的颈部和运动结构域突变与远端脊髓性肌萎缩及异常皮质发育相关。
Hum Mutat. 2014 Mar;35(3):298-302. doi: 10.1002/humu.22491. Epub 2014 Jan 3.
8
Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.可治疗的儿童神经元病由核黄素转运蛋白 RFVT2 的突变引起。
Brain. 2014 Jan;137(Pt 1):44-56. doi: 10.1093/brain/awt315. Epub 2013 Nov 19.
9
Amyotrophic lateral sclerosis (ALS)-associated VAPB-P56S inclusions represent an ER quality control compartment.肌萎缩侧索硬化症(ALS)相关 VAPB-P56S 包含物代表内质网质量控制区室。
Acta Neuropathol Commun. 2013 Jun 12;1:24. doi: 10.1186/2051-5960-1-24.
10
Gle1 functions during mRNA export in an oligomeric complex that is altered in human disease.Gle1 在多聚体复合物中发挥作用,该复合物在人类疾病中发生改变,参与 mRNA 输出。
Cell. 2013 Oct 24;155(3):582-93. doi: 10.1016/j.cell.2013.09.023.